Farkas E., Luiten P.G., Bari F., Permanent, bilateral common carotid artery occlusion in the rat: A model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res. Rev. 54: 162-180, 2007. Impact factor: 5,595
Gaspar T., Kis B., Snipes J.A., Lenzser G., Mayanagi K., Bari F., Busija D.W., Neuronal preconditioning with the antianginal drug, bepridil. J. Neurochem. 102: 595-608, 2007. Impact factor: 4,260
Annaházi A., Mracsko E., Süle Z., Karg E., Penke B., Bari F., Farkas E., Pre-treatment and post-treatment with alpha-tocopherol attenuates hippocampal neuronal damage in experimental cerebral hypoperfusion. Eur. J. Pharmacol. 571: 120-128, 2007. Impact factor: 2,522
Lenti L., Domoki F., Kis D., Hegyi O., Toth GK., Busija D.W., Bari F., Pituitary adenylate cyclase-activating polypeptide induces pial arteriolar vasodilation through cyclooxygenase-dependent and independent mechanisms in newborn pigs. Brain Res. 1165:81-88, 2007. Impact factor: 2,341
Institoris A., Farkas E., Berczi S., Sule Z., Bari F., Effects of cyclooxygenase (COX) inhibition on memory impairment and hippocampal damage in the early period of cerebral hypoperfusion in rats. Eur. J. Pharmacol. 574: 29-38, 2007. Impact factor: 2,522
Busija D.W., Bari F., Domoki F., Louis T., Mechanisms involved in the cerebrovascular dilator effects of N-methyl-d-aspartate in cerebral cortex. Brain. Res. Rev. 56: 89-100, 2007.
Impact factor: 5,595
Varga H., Pardutz A., Vamos E., Plangar I., Egyud E., Tajti J., Bari F., Vecsei L. Cox-2 Inhibitor Attenuates NO-Induced nNOS in Rat Caudal Trigeminal Nucleus. Headache. 47:1319-1325, 2007. Impact factor: 2,740
Atlasz T., Babai N., Reglodi D., Kiss P., Tamas A., Bari F., Domoki F., Gabriel R., Diazoxide is protective in the rat retina against ischemic injury induced by bilateral carotid occlusion and glutamate-induced degeneration. Neurotox. Res 12: 105-111, 2007. Impact factor: 2,000
Keri S., Benedek G., Janka Z., Vernier threshold and the parallel visual pathways in bipolar disorder: A follow-up study. Prog. Neuropsychopharmacol. Biol. Psychiat. 31: 86-91, 2007. Impact factor: 7,154
Nagy H., Keri S., Meyers C.E., Benedek G., Shohamy D., Gluck M.A., Cognitive sequence learning in Parkinson's disease and amnestic mild cognitive impairment: Dissociation between sequential and non-sequential learning of associations. Neuropsychologia 45: 1386-1392, 2007. Impact factor: 3,924
Janaky M., Palffy A., Deak A., Szilagyi M., Benedek G., Multifocal ERG reveals severals patterns of cone degeneration in retinitis pigmentosa with concentric narrowing of visual field. Invest. Ophtalmol. Visual Sci. 48: 383-389, 2007. Impact factor: 3,766
Berenyi A., Benedek G., Nagy A., Double sliding-window technique: A new method to calculate the neuronal response onset latency. Brain Res. 1178: 141-148, 2007. Impact factor: 2,341
Janaky M., Grosz A., Toth E., Benedek K., Benedek G., Hypobaric hypoxia reduces the amplitude of oscillatory potentials in the human ERG. Doc. Ophtalmol. 114: 45-51, 2007. Impact factor: 1,712
Nagy O., Kelemen O., Benedek G., Myers C.E., Shohamy D., Gluck M.A., Keri S., Dopaminergic contribution to cognitive sequence learning. J. Neural Transmis.114: 607-612, 2007. Impact factor: 2,938
Waleszczyk W.J., Nagy A., Wypych M., Berenyi A., Paroczy Z., Eordegh G., Ghazaryan A., Benedek G., Spectral receptive field properties of neurons in the feline superior colliculus. Exp. Brain Res. 181: 87-98, 2007. Impact factor: 1,959
Kelemen O., Nagy O., Matyasssy A., Bitter I., Benedek G., Vidnyanyzky Z., Keri S., How well do patients with schizophrenia track multiple moving targets? Neuropsychology 21: 319-325, 2007. Impact factor: 3,123
Keri S., Benedek G., Visual contrast sensitivity alterations in inferred magnocellular pathways and anomalous perceptual experiences in people at high-risk for psychosis. Vis. Neurosci. 24: 183-189, 2007. Impact factor: 1,484
Schwenger N., Dux M., de Col R., Carr R., Messlinger K., Interaction of calcitonin gene-related peptide, nitric oxide and histamine release in neurogenic blood flow and afferent activation in the rat cranial dura mater. Cephalalgia 27: 481-491, 2007. Impact factor: 6,049
Dux M., Rosta J., Pinter S., Santha P., Jancso G., Loss of capsaicin-induced meningeal neurogenic sensory vasodilatation in diabetic rats. Neuroscience 150: 194-201, 2007. Impact factor: 3,427
Peter-Szabo M., Kekesi G., Nagy E., Sziver E., Benedek G., Horvath G., Quantitative characterization of a repeated acute joint inflammation model in rats. Clin. Exp. Pharmacol. Physiol. 34: 520-526, 2007. Impact factor: 1,780
Nagy E., Feher-Kiss A., Barnai M., Domjan-Preszner A., Angyan I., Horvath G., Postural control in elderly subjects participating in balance training. Eur. J. Appl. Physiol. 100: 97-104, 2007. Impact factor: 1,601
Horvath G., Kekesi G., Tuboly G., Benedek G., Antinociceptive interactions of triple and quadruple combinations of endogenous ligands at the spinal level. Brain Res. 1155: 42-48, 2007. Impact factor: 2,341
Gram D., Ahren B., Nagy I., Olsen U., Brand C., Sundler F., Tabanera R., Svendsen O., Carr R, Santha P., Wierup N., Hansen A., Capsaicin-sensitive sensory fibres in the islet of Langerhans contribute to the defective insulin secretion in Zucker diabetic rat, an animal model for some aspects of human type 2 diabetes. Eur. J. Neurosci. 25: 213–223, 2007. Impact factor: 3,709
Baiou D., Santha P., Avelino A., Charrua A., Bacskai T., Matesz K., Cruz F., Nagy I., Neurochemical characterization of insulin receptor-expressing primary sensory neurons in wild-type and vanilloid type 1 transient receptor potential receptor knockout mice. J. Comp. Neurol. 503: 334-347, 2007. Impact factor: 3,831
Sary G., Chadaide Z., Tompa T., Koteles K., Kovacs G., Benedek G., Illusory shape representation in the monkey inferior temporal cortex. Eur. J. Neurosci. 25: 2558-2564, 2007. Impact factor: 3,709
Alt J.A., Bohnet S., Taishi P., Duricka D., Obal F.Jr., Traynor T., Majde J.A., Krueger J.M., Influenza virus-induced glucocorticoid and hypothalamic and lung cytokine mRNA responses in dwarf lit/lit mice. Brain. Behav. Immun. 21: 60-67, 2007. Impact factor: 3,757
|